The expression of BNIP3 in different tumors is inconsistent, and its high expression in tumors such as lung cancer, prostate cancer, breast cancer, and endometrial cancer is associated with a bleak prognosis for patients diagnosed with tumors. Here, BNIP3 is linked to endometrial cancer.